ステージIIIa/IIIb結腸直腸癌に対するウラシルとテガフール/ロイコボリン（UFT/LV）療法とUFT/LV+多糖体K（PSK）療法の比較

基本情報

NCT ID: NCT00497107
ステータス: 不明
試験のフェーズ: 第3相
試験タイプ: 介入
目標被験者数: 300
治験依頼者名: Iwate Medical University

概要

The purpose of this study is to conduct a randomised controlled trial (RCT) comparing UFT/LV and UFT/LV + PSK in patients with histological stage IIIa/IIIb colorectal cancer who have undergone curative surgery without residual cancer using 3-year disease free survival (DFS) as the primary endpoint, and also to analyze the 3-year overall survival (OS), compliance, adverse events, quality of life (QOL) and relationship with tumor factors.

対象疾患

Colorectal Cancer

介入

UFT, Calcium Folinate, PSK(DRUG)

UFT, Calcium Folinate(DRUG)

依頼者（Sponsor）

Iwate Medical University(OTHER)

実施施設 (1)

岩手医科大学附属病院

Morioka, Iwate, Japan(RECRUITING)